Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000467728 | SCV000529345 | benign | not provided | 2018-06-24 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001084152 | SCV000554289 | benign | Alstrom syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000427899 | SCV000967035 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Ser1064Pro in exon 8 of ALMS1: This variant is not expected to have clinical s ignificance because it has been identified in 1.58% (155/9794) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs28730852). |
Athena Diagnostics | RCV000467728 | SCV001143000 | benign | not provided | 2018-09-14 | criteria provided, single submitter | clinical testing | |
Personalized Diabetes Medicine Program, |
RCV001172514 | SCV001335567 | benign | Monogenic diabetes | 2018-05-18 | criteria provided, single submitter | research | ACMG criteria: BP4 (9 predictors, Revel score 0.018), BS2 (35 cases and 38 controls in type2diabetesgenetics.org, 3 homozygotes in gnomAD), BP1, BS1 (MAF 1.7% in gnomAD Africans)= benign |
Clinical Genomics, |
RCV001084152 | SCV002605252 | benign | Alstrom syndrome | criteria provided, single submitter | research | Potent mutations in ALMS1 are associated with a rare condition called Alstrom syndrome. It can cause excessive eating, insulin resistance. However, no evidence is found to ascertain the role of rs28730852 in Alstrom syndrome yet. | |
Ambry Genetics | RCV002323633 | SCV002609656 | benign | Cardiovascular phenotype | 2019-01-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV001084152 | SCV002798779 | likely benign | Alstrom syndrome | 2021-09-14 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001084152 | SCV004563832 | likely benign | Alstrom syndrome | 2023-08-16 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000467728 | SCV001797355 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000427899 | SCV001921982 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000427899 | SCV001932942 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000427899 | SCV001966279 | benign | not specified | no assertion criteria provided | clinical testing |